RPGR rs121912525: Understanding This Rare Vision-Related Variant
The rs121912525 variant is a rare genetic change located within the RPGR gene. It is associated with X-linked retinitis pigmentosa, a condition characterized by progressive vision loss and retinal degeneration.
What each genotype means
Typical RPGR gene sequence
This genotype represents the common, non-variant sequence for this specific location in the RPGR gene. It is not associated with the X-linked retinitis pigmentosa described in clinical literature for this variant.
This is the most common genotype found in the general population across all ancestries.
Heterozygous carrier status
As this variant is X-linked, females with this genotype are carriers. Research indicates that female carriers may exhibit a milder phenotype compared to males, often showing interocular asymmetry in visual function.
This genotype is extremely rare and essentially absent in broad, non-disease population cohorts.
Hemizygous variant presence
In males, who have only one X chromosome, this genotype indicates the presence of the pathogenic variant. This is associated with X-linked retinitis pigmentosa, which can lead to progressive night blindness and constricted visual fields.
This genotype is extremely rare and essentially absent in broad, non-disease population cohorts.
What is the rs121912525 Variant?
The rs121912525 variant is a specific change in the DNA sequence of the RPGR gene. In genetic terms, it is classified as a nonsense variant, meaning it introduces a premature stop signal in the genetic instructions. This alteration prevents the cell from producing a full-length, functional protein. Because the RPGR gene is located on the X chromosome, this variant follows an X-linked inheritance pattern. This means that males, who have only one X chromosome, are typically more severely affected if they inherit the variant, as they lack a second, functional copy of the gene to compensate. Females, who have two X chromosomes, may be carriers and can exhibit a range of symptoms depending on the process of X-chromosome inactivation in their retinal cells.
The Role of the RPGR Gene
The RPGR gene provides instructions for making a protein called retinitis pigmentosa GTPase regulator. This protein is primarily found in the photoreceptor cells of the retina, which are the specialized cells in the eye that detect light and convert it into electrical signals for the brain. The RPGR protein plays a critical role in the transport of proteins between different parts of these photoreceptor cells, specifically between the inner and outer segments. Proper protein trafficking is essential for the survival and function of rods and cones. When the RPGR protein is absent or dysfunctional due to a pathogenic variant, these transport processes are disrupted, leading to the gradual death of photoreceptor cells and the characteristic vision loss associated with retinitis pigmentosa.
Research and Clinical Associations
Research has established that variants in the RPGR gene are a leading cause of X-linked retinitis pigmentosa, accounting for a significant portion of cases. The rs121912525 variant is specifically noted in clinical databases for its association with this condition. Clinical presentations typically include night blindness, which often begins in childhood or adolescence, followed by a progressive constriction of the visual field, commonly referred to as tunnel vision. While the evidence linking this specific variant to the disease is strong within the context of clinical genetics, it is important to note that the severity and progression of the condition can vary between individuals. Current research is heavily focused on gene therapy approaches, such as using viral vectors to deliver a functional copy of the RPGR gene to the retina, aiming to stabilize or restore vision in affected patients.
Population Frequency and Prevalence
The rs121912525 variant is considered extremely rare in the general population. It is essentially absent from large-scale, non-disease-focused genomic databases like gnomAD, which aggregate data from thousands of individuals across diverse ancestries. Its presence is primarily identified in clinical settings among families or individuals already diagnosed with or suspected of having inherited retinal dystrophies. Because it is not a common polymorphism found in the general public, it is not typically included in standard direct-to-consumer genetic health screening panels. Its rarity underscores that it is a pathogenic variant rather than a common genetic difference that contributes to normal human variation.
What This Information Means for You
If you have received information regarding this variant, it is essential to understand that genetic results should always be interpreted by a qualified healthcare professional, such as a genetic counselor or an ophthalmologist specializing in retinal diseases. This variant is associated with a serious medical condition, and its presence does not automatically guarantee a specific clinical outcome, as other genetic and environmental factors can influence disease expression. You cannot use this information to self-diagnose or predict the exact course of a condition. If you are concerned about your vision or family history, consult with a medical specialist who can provide appropriate clinical testing, diagnostic confirmation, and guidance on potential management or participation in clinical trials for emerging therapies.
How common is this variant?
The rs121912525 variant is a rare X-linked variant that is essentially absent in broad gnomAD non-disease cohorts.
Frequently asked questions
Is rs121912525 a common genetic variant?
No, this variant is extremely rare and is not found in the general population. It is typically only identified in clinical settings among individuals with specific retinal conditions.
What does it mean if I have this variant?
The presence of this variant is associated with X-linked retinitis pigmentosa. You should discuss these results with a genetic counselor or an eye specialist to understand the clinical implications for your health.
Can this variant be treated?
There is currently no cure for RPGR-associated retinitis pigmentosa, but there is significant ongoing research into gene therapy. Clinical trials are investigating ways to deliver functional copies of the gene to the retina.
Does this variant affect both men and women?
Yes, but it affects them differently. Males with the variant are typically more severely affected, while females may be carriers and can experience a range of symptoms depending on X-chromosome inactivation.
Sources & further reading
Educational information only, last refreshed 9/22/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121912525?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29